The 10X Genomics Xenium Analyzer will support true single cell spatial transcriptomics on fresh frozen or fixed tissue samples. You can characterize 100s to 1000s of RNAs in cells and tissues using ...
PLEASANTON, Calif. and PARIS, Nov. 6, 2023 /PRNewswire/ -- OWKIN and 10x Genomics, Inc. (TXG), announce they have entered into an agreement to add 10x Genomics spatial omics and single-cell ...
PLEASANTON, Calif., Feb. 23, 2025 /PRNewswire/ -- At the Advances in Genome Biology and Technology (AGBT) General Meeting, 10x Genomics, Inc., a leader in single cell and spatial biology, announced a ...
Hosted on MSN
What Is Spatial Transcriptomics?
Spatial transcriptomics is a technique that provides information about gene expression patterns within intact tissues. This technology employs various methodologies, including in situ sequencing (ISS) ...
Pleasanton, Calif.-based 10x Genomics, a biotechnology startup developing single-cell and whole genome sequencing technologies, filed a prospectus with the SEC Aug. 19 for an initial public offering ...
The "Spatial Genomics and Transcriptomics Market Analysis and Forecast, 2024-2034" report has been added to ResearchAndMarkets.com's offering.
Spatial ribonucleic acid (RNA) transcriptomics measures gene expression while preserving each molecule’s coordinates in intact tissue, tying transcripts to histology and local microenvironments.
10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell transcriptomics, ...
In a report released yesterday, Patrick B Donnelly from Citi maintained a Buy rating on 10x Genomics (TXG – Research Report), with a price target of $23.00. Patrick B Donnelly has given his Buy rating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback